China's dimethylformamide market finished June under clear downward pressure, as weekly assessments show ongoing destocking and rising inventories pressuring prices. Early-June dimethylformamide quotes were largely stable, but the market slid through mid-month on soft buying, settling into a narrow range at month-end. Overall sentiment remained bearish, with a pronounced month-on-month correction in dimethylformamide pricing and cautious downstream procurement cited as key near-term headwinds. Demand patterns were uneven: coatings, adhesives and industrial solvents proved soft as monsoon slowdowns curbed summer consumption and converters bought dimethylformamide on a hand-to-mouth basis. In contrast, polyurethane and adhesive producers showed modest support ahead of a seasonal rebound into September. Pharmaceutical buyers could provide upside later in the year, with stronger API and intermediate buying possibly prompting forward dimethylformamide purchases. On the supply side, several dimethylformamide facilities resumed post-maintenance, lifting output and inventories; operating rates remained at elevated levels, expanding spot availability. Looking forward, downside pressure is expected to persist through July, though seasonal restocking or stronger pharmaceutical demand could offer temporary support.
China's dimethylformamide (DMF) market finished June under clear downward pressure, with weekly assessments showing a fall of 0.83% in late June as sellers competed to move rising inventories. Early June began with largely stable dimethylformamide quotations, but the market slid through mid-month amid soft buying before settling into a range-bound posture at month-end. Overall sentiment was bearish for June, reflected in a pronounced month-on-month correction, while market participants highlighted monsoon-season demand weakness and cautious downstream procurement as the main near-term headwinds for dimethylformamide trading.
Demand patterns across downstream sectors were uneven. The coatings, adhesives and industrial-solvent segments were notably soft as monsoon slowdowns curtailed typical summer consumption and converters largely bought dimethylformamide on a hand-to-mouth basis, reducing replenishment activity. In contrast, polyurethane and adhesive manufacturers showed signs of moderate support as some players prepared dimethylformamide inventories ahead of an expected seasonal rebound toward September. Pharmaceutical buyers were flagged as a potential upside later in the year, with scenarios wherein stronger API and intermediate buying could prompt forward dimethylformamide purchases and amplify any upward move, according to market notes.
Supply dynamics added to the downward pressure on dimethylformamide prices. Several major dimethylformamide facilities resumed production after April maintenance, lifting overall output and contributing to higher inventories at both plant and social-storage levels; per ChemAnalyst data, operating rates ran above 75%, increasing spot availability of dimethylformamide. Feedstock methanol remained broadly stable in June, keeping immediate dimethylformamide production costs steady, yet analysts warned that geopolitical disruptions in Gulf supply routes could tighten spot methanol availability and push opportunity costs higher. A notable maintenance outage at Shaanxi Xinghua Group's Xianyang facility ran through much of June, but the broader restart trend had already eased tightness and supported competitive dimethylformamide selling.
Weekly movement through June showed gradual softening rather than sharp swings in dimethylformamide prices: quotations were stable in early June, slipped modestly mid-month, and then declined by 0.83% in late June per weekly assessment data before settling into a narrow range. That pattern fits a market where sellers are offering dimethylformamide material to destock while buyers remain cautious; small week-to-week declines extended a multi-week bearish trend without triggering any abrupt tightness.
Looking ahead, our analysts see downside pressure persisting near term, with dimethylformamide prices anticipated to decrease further in July based on current market trends. Key drivers include continued monsoon-season weakness in coatings and adhesives, conservative dimethylformamide procurement amid geopolitical uncertainty, and the risk that improved methanol availability keeps production economics favourable to sellers. Conversely, seasonal restocking around Golden Week or stronger pharmaceutical buying could provide temporary support for dimethylformamide markets.
